Reporter and Curator: Dr. Sudipta Saha, Ph.D. Leigh syndrome is one of the hundreds of so-called mitochondrial diseases, which are caused by defects in the mitochondria that produce 90 percent of the body’s energy. These disorders are rare; about 1,000 to 4,000 babies in the United States are born with one every year. But they are devastating and […]
Search Results for 'mitochondria'
Mitochondria Replacement Therapy
Posted in Cell Biology, Cell Biology, Signaling & Cell Circuits, cell-based therapy, Developmental biology, Embryology, Gene Therapy & Gene Editing Development, Preimplantation Genetic Diagnosis and Reproductive Genomics, Reproductive Andrology, Embryology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics, Reproductive Biology & Bio Instrumentation, Signaling & Cell Circuits, Single Cell Genomics, stem cell biology and patient-specific, tagged genetic engineering, IVF, Leigh syndrome, mitochondria, Replacement on April 14, 2019| Leave a Comment »
The Three Parent Technique to Avoid Mitochondrial Disease in Embryo
Posted in Cell Biology, Developmental biology, Disease Biology, DNA repair, Gene Regulation, Genetics & Innovations in Treatment, Genomic Testing: Methodology for Diagnosis, Innovations, Reproductive Andrology, Embryology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics, tagged IVF, Maternal Spindle Transfer, Mitochondria Donation, Mitochondrial DNA, Pro-nuclear Transfer, Three Parent Technique on October 7, 2016| Leave a Comment »
Reporter and Curator: Dr. Sudipta Saha, Ph.D. Mitochondrial disease Mitochondria are present in almost all human cells, and vary in number from a few tens to many thousands. They generate the majority of a cell’s energy supply which powers every part of our body. Mitochondria have their own separate DNA, which carries just […]
Drugs that activate this novel stress response pathway, which they call the mitochondrial-to-cytosolic stress response, protected both nematodes and cultured human cells with Huntington´s disease from protein-folding damage.
Posted in Innovations in Neurophysiology & Neuropsychology on September 24, 2016| Leave a Comment »
Drugs that activate this novel stress response pathway, which they call the mitochondrial-to-cytosolic stress response, protected both nematodes and cultured human cells with Huntington´s disease from protein-folding damage. Reporter: Aviva Lev-Ari, PhD, RN “Maybe there is a way to use one drug to alter the mitochondrial signal and another drug to alter the communciation […]
Stem Cell Transplants Can Trigger Immune Reaction to Cell’s Mitochondria
Posted in Cell Biology, Signaling & Cell Circuits, Embryology, Regenerative Biology and Medicine, tagged immune rejection, Induced pluripotent stem cell, regenerative medicine, SCNT, somatic cell nuclear transfer, Stem Cell Biology and Regenerative Medicine on November 21, 2015| Leave a Comment »
Previously unseen immune reaction identified for stem cell transplants. Reporter: Stephen J. Williams, Ph.D. Reposted from Healthinnovations at http://health-innovations.org/2014/11/21/previously-unseen-immune-reaction-identified-in-stem-cell-transplants/ Mouse cells and tissues created through nuclear transfer can be rejected by the body because of a previously unknown immune response to the cell’s mitochondria, according to an international study in mice by researchers at the […]
EMBRACE-STEMI: Drug targeting mitochondria does not reduce infarct size – Healio
Posted in Uncategorized on April 21, 2015| Leave a Comment »
SAN DIEGO — The novel drug Bendavia did not meet any of its primary or secondary endpoints in a trial assessing its use prior to primary PCI in patients with STEMI, according to data presented at the American College of Cardiology Scientific Sessions.Patients… Source: http://www.healio.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY
Advertisements
-
Recent Posts
- Complex rearrangements and oncogene amplification revealed by long-read DNA and RNA sequencing of a breast cancer cell line August 14, 2019
- All Inputs in Consideration for Pricing LPBI Group’s IP Three Classes of Assets August 12, 2019
- For @AVIVA1950, Founder, LPBI Group @pharma_BI: Twitter Analytics [Engagement Rate, Link Clicks, Retweets, Likes, Replies] & Tweet Highlights [Tweets, Impressions, Profile Visits, Mentions, New Followers] August 6, 2019
- Using A.I. to Detect Lung Cancer gets an A! August 4, 2019
- Disentangling molecular alterations from water-content changes in the aging human brain using quantitative MRI August 1, 2019
- The Digital Age Gave Rise to New Definitions – New Benchmarks were born on the World Wide Web for the Intangible Asset of Firm’s Reputation: Pay a Premium for buying e-Reputation July 31, 2019
- Forbes Opinion: 13 Industries Soon To Be Revolutionized By Artificial Intelligence July 31, 2019
- Broad@15 – In 2004, the Broad Institute of MIT and Harvard launched with a mission to improve human health July 31, 2019
- MinneBOS 2019 Field Guide to Data Science & Emerging Tech in the Boston Community, August 22, 2019 8AM to 5PM at Boston University Questrom School of Business, 595 Commonwealth Avenue, Boston, MA July 31, 2019
- The Sylvester Comprehensive Cancer Center of the University of Miami named 71st NCI designated Cancer Center July 30, 2019
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
amnondanzig1724
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
Advertisements
